PMID: 40381Jul 1, 1979

Developments in understanding the physiology and pharmacology of parkinsonism

Acta Neurologica Scandinavica
H Teräväinen, D B Calne

Abstract

While the era of major advances in understanding and treating parkinsonism seems to be over, steady progress is being made in elucidating physiological and pharmacological aspects of extrapyramidal function. The dramatic impact of levodopa therapy has been followed by the recognition of serious limitations to its long-term use, which provides a continuing stimulus for efforts to analyze the physiological and pharmacological properties of the basal ganglia and substantia nigra. There are reasonable grounds for the hope that this research will lead to significant developments in therapy.

References

Apr 27, 2005·Movement Disorders : Official Journal of the Movement Disorder Society·Stephane ThoboisPatricia Limousin-Dowsey

Citations

Apr 1, 1976·The Journal of Pharmacy and Pharmacology·A Dray, D W Straughan
Oct 15, 1977·Lancet·A J LeesM B Youdim
Apr 8, 1978·Lancet·D B CalneP F Teychenne
Nov 18, 1978·Lancet·P PriceC D Marsden
Jan 11, 1979·Nature·J W Kebabian, D B Calne
Mar 1, 1978·Brain : a Journal of Neurology·K Flowers
Sep 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·J W KebabianJ Axelrod
Oct 1, 1973·Journal of Neurology, Neurosurgery, and Psychiatry·D J Horne
Jan 1, 1970·Experimental Brain Research·C OhyeL J Poirier
Dec 1, 1971·Neurology·R W AngelH Garland
Dec 1, 1965·Brain : a Journal of Neurology·F Buchthal, M L Fernandez-Ballesteros
Oct 26, 1963·Nature·H J HUFSCHMIDT

Related Concepts

Entire Basal Nuclei
Substantia Nigra Structure
Parkinsonian Disorders
Nervous System Structure
Entire Substantia Nigra
Neurohormones
Dopamine Receptor
Claustral Structure
Parkinson Disease
Levopa

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Basal ganglia in Parkinson's disease (MDS)

The basal ganglia is comprised of the neostriatum, the external and internal pallidal segments, the subthalamic nucleus, the substantia nigra pars reticulata, and the pars compacta of the substantia nigra. The basal ganglia circuitry is responsible for the correct execution of voluntary movements and is implicated in Parkinson's disease. Here is the latest research investigating the basal ganglia in Parkinson's disease.

© 2020 Meta ULC. All rights reserved